Publication | Closed Access
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders
138
Citations
25
References
2013
Year
HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyNull RespondersAntiviral DrugMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1